ReviewJournal of thoracic disease2019
Mesenchymal tumors of the lung: diagnostic pathology, molecular pathogenesis, and identified biomarkers.
Review in Journal of thoracic disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 20 citations in OpenAlex.
- Novel immunohistochemical assay utilizing the INSM1 (SP493) antibody demonstrates high specificity and sensitivity in detecting primary neuroendocrine lung neoplasms.Diagnostic pathology · 2025Article
- ECMO and rigid bronchoscopy-assisted surgical resection of a giant pulmonary mesenchymal tumor in a child: a case report.BMC pediatrics · 2025Article
- Article
- Endobronchial hamartomas as a rare cause of chronic cough.Respiratory medicine case reports · 2025Article
- Comments and Illustrations of the European Federation of Societies for Ultrasound in Medicine (EFSUMB) Guidelines: Rare Malignant Pulmonal and Pleural Tumors: Primary Pulmonary Sarcoma and Mesothelioma, Imaging Features on Transthoracic Ultrasound.Diagnostics (Basel, Switzerland) · 2024Review
- Identification of CT Features to Differentiate Pulmonary Sarcoma from Carcinoma.The Indian journal of radiology & imaging · 2024Article
- Primary pulmonary myxoid sarcoma with EWSR1::CREB1 fusion: a literature review.Journal of cancer research and clinical oncology · 2024Review
- Case Report: Giant lung hamartoma : An usual cause of lobectomy in a five-year child.F1000Research · 2024Article
- CT findings of a large primary pulmonary myxoid sarcoma: A case report.Radiology case reports · 2022Article
- Case Report: Hemangioblastoma- Like Clear Cell Stromal Tumor of the Left Lower Lung.Frontiers in medicine · 2022Article
- Morphologic Spectrum of Undetermined Causes of Hemoptysis- A Pathologist's Role.Turk patoloji dergisi · 2020Article
- The clinicopathological challenges of symptomatic and incidental pulmonary hamartomas diagnosis.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologieArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung cancers are mainly composed of epithelial tumors such as carcinomas. Since mesenchymal tumors that arise in the lung are very rare, they have garnered little attention. The 2015 World Health Organization (WHO) classification of lung tumors has undergone revision, not only for carcinomas but also for mesenchymal tumors. The current version now includes PEComatous tumors, myoepithelial tumors, and pulmonary myxoid sarcomas with
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.